Immunity to immunogenic tumor variants analysis of variant specific and parental cross protective immunity in vivo
Legrue, S.J.; Simcik, W.
Journal of Cellular Biochemistry Suppl (13 Part A): 322
1989
ISSN/ISBN: 0730-2312
Accession: 031807695
PDF emailed within 1 workday: $29.90
Related References
Legrue, S.J.; Ananthaswamy, H.N.; Simcik, W.J. 1989: Afferent and efferent specificity in the induction and elicitation of parental cross-protective immunity by an immunogenic murine tumor variant: associative recognition of a unique tumor-specific antigen on somatic cell hybrids Cancer Research 49(17): 4747-4751Simcik, W.; Sheu, T.L.; LeGrue, S.J. 1989: Characterization of variant and parental-cross-protective immunity to immunogenic variants of a murine fibrosarcoma using the local adoptive transfer assay Cancer Immunology Immunotherapy: Cii 30(4): 219-226
Ting, C.C.; Rodrigues, D.; Nordan, R. 1982: Studies of the mechanisms for the induction of in vivo tumor immunity. VI. Induction of specific and nonspecific cell-mediated immunity in tumor-bearing hosts and its correlation with transplantation tumor immunity Cellular Immunology 66(1): 45-58
Edelman, A.S.; Xue, B.; Sanchez, P.; Thorbecke, G.J. 1985: Cross-reactive cellular and humoral immunity to carcinogen-induced chicken fibrosarcomas. I. Protective cross-immunity between transplantable tumor lines Journal of Immunology 135(3): 2206-2212
Edelman, A.S.; Bin, X.U.E.; Sanchez, P.; Thorbecke, G.J. 1985: Cross-reactive cellular and humoral immunity to carcinogen-induced chicken fibrosarcomas. I: Protective cross-immunity between transplantable tumor lines The Journal of Immunology (1950) 135(3): 2206-2212
Yoshioka, T.; Fukuzawa, M.; Takai, Y.; Wakamiya, N.; Ueda, S.; Kato, S.; Fujiwara, H.; Hamaoka, T. 1986: The augmentation of tumor-specific immunity by virus help. III: enhanced generation of tumor-specific Lyt-1+2-T cells is reponsible for augmented tumor immunity in vivo Cancer Immunology and ImmunoTherapy 21(3): 193-198
Yoshioka, T.; Fukuzawa, M.; Takai, Y.; Wakamiya, N.; Ueda, S.; Kato, S.; Fujiwara, H.; Hamaoka, T. 1986: The augmentation of tumor-specific immunity by virus help. III. Enhanced generation of tumor-specific Lyt-1+2- T cells is responsible for augmented tumor immunity in vivo Cancer Immunology Immunotherapy: Cii 21(3): 193-198
Bosslet, K.; Schirrmacher, V.; Shantz, G. 1979: Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. VI. Similar specificity patterns of protective anti-tumor immunity in vivo and of cytolytic T cells in vitro International Journal of Cancer 24(3): 303-313
Sano, S.; Izumi, Y.; Sugihara, S.; Nakajima, H.; Fujiwara, H.; Hamaoka, T. 1987: The generation of tumor-specific in vivo protective immunity in the tumor mass from mice rendered tolerant to tumor antigens Cancer Immunology Immunotherapy: Cii 25(2): 105-110
Fujiwara, H.; Hamaoka, T. 1988: Cellular mechanisms of tumor rejection in vivo and enhanced induction of anti tumor protective immunity applicable to tumor-specific immunotherapy Progress in Experimental Tumor Research 32: 69-103
Dan, Q.; Sanchez, R.; Delgado, C.; Wepsic, H.T.; Morgan, K.; Chen, Y.; Jeffes, E.W.; Lowell, C.A.; Morgan, T.R.; Jadus, M.R. 2001: Non-immunogenic murine hepatocellular carcinoma Hepa1-6 cells expressing the membrane form of macrophage colony stimulating factor are rejected in vivo and lead to CD8+ T-cell immunity against the parental tumor Molecular Therapy: the Journal of the American Society of Gene Therapy 4(5): 427-437
Brown, M.D.; van der Most, R.; Vivian, J.B.; Lake, R.A.; Larma, I.; Robinson, B.W.S.; Currie, A.J. 2012: Loss of antigen cross-presentation after complete tumor resection is associated with the generation of protective tumor-specific CD8(+) T-cell immunity Oncoimmunology 1(7): 1084-1094
Schirrmacher, V.; Griesbach, A.; Umansky, V.; Rocha, M. 1994: Adoptive transfer of protective immunity against a high metastatic tumor-cell variant by small numbers of tumor-specific in-situ activated peritoneal effector T-cells International Journal of Oncology 5(2): 141-151
Ting, C.C.; Zhang, S.R. 1983: Studies of the mechanisms for the induction of in vivo tumor immunity. VII. Development of specific antitumor immunity in progressors and regressors International Journal of Cancer 32(3): 385-391
Brannen, G.E.; Adams, J.S.; Santos, G.W. 1974: Tumor-specific immunity in 3-methylcholanthrene-induced murine fibrosarcomas. I. in vivo demonstration of immunity with three preparations of soluble antigens Journal of the National Cancer Institute 53(1): 165-175